FIELD: medicine, virology, biochemistry.
SUBSTANCE: invention relates to a method for treatment or prophylaxis of infections caused by a related virus in animal, such as SIV, FIV or AIDS, and to using some inhibitors of cyclooxygenase isoform-2 (COX-2) by this designation. Preferable COX-2 inhibitors are L-745337, rofecoxibe, NS398, SC58125, etodolac, meloxicam, celecoxib, DuP-697, DFU, tricyclic MF, valdecoxib, paraoxib-sodium, etoricoxib or nimesulide relating to nonsteroid anti-inflammatory drugs. They improve immune functions of T-cells, reduce or eliminate the immunodeficient state.
EFFECT: improved method of prophylaxis, valuable medicinal properties of drugs.
24 cl, 18 dwg, 6 tbl, 7 ex
| Title | Year | Author | Number |
|---|---|---|---|
| LIGAND GITR AND MOLECULES AND ANTIBODIES BOUND WITH LIGAND GITR, AND VERSIONS OF THEIR APPLICATION | 2004 |
|
RU2369636C2 |
| COMPOSITIONS AND METHODS OF TREATING INFECTIONS AND TUMOURS | 2007 |
|
RU2540490C2 |
| ANTIVIRAL IMMUNOTHERAPY BY MEMBRANE RECEPTOR LIGATION | 2017 |
|
RU2773427C2 |
| COMPOSITIONS AND METHODS OF TREATING INFECTIONS AND TUMOURS | 2007 |
|
RU2478400C2 |
| METHODS AND COMPOSITIONS FOR TREATMENT OF PERSISTENT INFECTIONS | 2016 |
|
RU2746383C2 |
| METHODS AND COMPOSITIONS FOR TREATING PERSISTENT INFECTIONS | 2006 |
|
RU2596491C2 |
| METHOD AND COMPOSITIONS FOR TREATMENT OF PERSISTING INFECTIONS | 2006 |
|
RU2434641C2 |
| PHARMACEUTICAL COMPOSITION FOR PREVENTING AND/OR TREATING HIV DISEASE IN HUMANS | 2012 |
|
RU2609769C2 |
| DELIVERY OF BIOMOLECULES INTO CELLS OF IMMUNE SYSTEM | 2015 |
|
RU2739794C2 |
| METHODS FOR INDUCING OF PROLONGED IMMUNE RESPONSE | 2002 |
|
RU2313364C2 |
